Abstract
Liver fibrosis (LF) is the wound healing response to chronic liver injury. LF is the endpoint of chronic liver disease (CLD) regardless of etiology and the single most important determinant of long-term liver-related clinical outcomes. Quantification of LF is important for staging, to evaluate response to treatment and to predict outcomes. LF is traditionally staged by liver biopsy. However, liver biopsy is invasive and suffers from sampling errors when biopsy size is inadequate; therefore, non-invasive tests (NITs) have found important roles in clinical care. NITs include simple laboratory-based serum tests, panels of serum tests, and imaging biomarkers. NITs are validated against the liver biopsy and will be used in the future for evaluation of nearly all CLDs with invasive liver biopsy reserved for some cases. Both serum tests and some imaging biomarkers such as elastography are currently used clinically as surrogate markers for LF. Several other imaging biomarkers are still considered research and awaiting clinical application in the future. As the evaluation of imaging biomarkers will likely become the norm in the future, understanding pathogenesis of LF is important. Knowledge of properties measured by imaging biomarkers and its correlation with LF is important to understand the application of NITs by abdominal radiologists. In this review, we present a brief overview of pathogenesis of LF, spatiotemporal evolution of LF in different CLD, and severity assessment with liver biopsy. This will be followed by a brief discussion on properties measured by imaging biomarkers and their relationship to the LF.
Similar content being viewed by others
Data availability
No data available.
References
Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH (1977) The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ 55 (4):521-540
Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425-456. https://doi.org/10.1146/annurev-pathol-011110-130246
Rosenberg WM (2003) Rating fibrosis progression in chronic liver diseases. J Hepatol 38 (3):357-360. https://doi.org/10.1016/s0168-8278(03)00010-2
Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F (2015) Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 149 (2):389-397.e310. https://doi.org/10.1053/j.gastro.2015.04.043
Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42 (8):2037-2053. https://doi.org/10.1007/s00261-017-1211-7
Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology (Baltimore, Md) 43 (2 Suppl 1):S113-120. https://doi.org/10.1002/hep.21046
Rockey DC (2008) Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 134 (1):8-14. https://doi.org/10.1053/j.gastro.2007.11.053
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, Diseases AAftSoL (2009) Liver biopsy. Hepatology (Baltimore, Md) 49 (3):1017-1044. https://doi.org/10.1002/hep.22742
Petitclerc L, Gilbert G, Nguyen BN, Tang A (2017) Liver Fibrosis Quantification by Magnetic Resonance Imaging. Top Magn Reson Imaging 26 (6):229-241. https://doi.org/10.1097/rmr.0000000000000149
Yin M, Venkatesh SK (2018) Ultrasound or MR elastography of liver: which one shall I use? Abdom Radiol (NY) 43 (7):1546-1551. https://doi.org/10.1007/s00261-017-1340-z
Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions. AJR Am J Roentgenol 205 (1):33-40. https://doi.org/10.2214/AJR.15.14553
Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME (2019) Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 213 (1):77-89. https://doi.org/10.2214/AJR.19.21144
Sun M, Kisseleva T (2015) Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol 39 Suppl 1:S60-63. https://doi.org/10.1016/j.clinre.2015.06.015
Geerts A (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21 (3):311-335. https://doi.org/10.1055/s-2001-17550
Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P (2003) A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38 (3):257-265
Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115 (2):209-218. https://doi.org/10.1172/JCI24282
Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233 (2):109-122. https://doi.org/10.3181/0707-MR-190
Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP (2006) An appraisal of the histopathological assessment of liver fibrosis. Gut 55 (4):569-578. https://doi.org/10.1136/gut.2005.084475
Brenner DA, Waterboer T, Choi SK, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A, Rippe RA (2000) New aspects of hepatic fibrosis. J Hepatol 32 (1 Suppl):32-38. https://doi.org/10.1016/s0168-8278(00)80413-4
Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJ, Benyon RC, Iredale JP (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126 (7):1795-1808. https://doi.org/10.1053/j.gastro.2004.03.009
Pellicoro A, Aucott RL, Ramachandran P, Robson AJ, Fallowfield JA, Snowdon VK, Hartland SN, Vernon M, Duffield JS, Benyon RC, Forbes SJ, Iredale JP (2012) Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology (Baltimore, Md) 55 (6):1965-1975. https://doi.org/10.1002/hep.25567
Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36 (4):231-242. https://doi.org/10.1016/j.dld.2004.01.003
Safdar K, Schiff ER (2004) Alcohol and hepatitis C. Semin Liver Dis 24 (3):305-315. https://doi.org/10.1055/s-2004-832942
Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA (2004) Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10 (10):1248-1255. https://doi.org/10.1002/lt.20232
Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (Baltimore, Md) 30 (4):1054–1058. https://doi.org/10.1002/hep.510300409
McGuire RF, Bissell DM, Boyles J, Roll FJ (1992) Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology 15 (6):989-997. https://doi.org/10.1002/hep.1840150603
Hammoutene A, Rautou PE (2019) Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol 70 (6):1278-1291. https://doi.org/10.1016/j.jhep.2019.02.012
Lee JS, Semela D, Iredale J, Shah VH (2007) Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45 (3):817-825. https://doi.org/10.1002/hep.21564
Parola M, Pinzani M (2019) Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37-55. https://doi.org/10.1016/j.mam.2018.09.002
POPPER H, ELIAS H, PETTY DE (1952) Vascular pattern of the cirrhotic liver. Am J Clin Pathol 22 (8):717-729. https://doi.org/10.1093/ajcp/22.8.717
HALES MR, ALLAN JS, HALL EM (1959) Injection-corrosion studies of normal and cirrhotic livers. Am J Pathol 35:909-941
Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18 (3):151-166. https://doi.org/10.1038/s41575-020-00372-7
Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV (2008) Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 28 (10):1175-1187. https://doi.org/10.1111/j.1365-2036.2008.03840.x
Serpaggi J, Carnot F, Nalpas B, Canioni D, Guechot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S (2006) Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 37 (12):1519-1526. https://doi.org/10.1016/j.humpath.2006.07.007
Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A (2009) Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair 2 (1):2. https://doi.org/10.1186/1755-1536-2-2
Ellis EL, Mann DA (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56 (5):1171-1180. https://doi.org/10.1016/j.jhep.2011.09.024
Vukobrat-Bijedic Z, Husic-Selimovic A, Mehinovic L, Mehmedovic A, Junuzovic D, Bjelogrlic I, Sofic A, Djurovic A (2014) Analysis of effect of antiviral therapy on regression of liver fibrosis in patient with HCV infection. Mater Sociomed 26 (3):172-176. https://doi.org/10.5455/msm.2014.26.172-176
Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Fléjou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Lévy P (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344 (6):418-423. https://doi.org/10.1056/NEJM200102083440604
Arthur MJ (2002) Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122 (5):1525-1528. https://doi.org/10.1053/gast.2002.33367
Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, Fried MW, Burkhardt E (2001) Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 35 (6):749-755. https://doi.org/10.1016/s0168-8278(01)00218-5
Dixon JB, Bhathal PS, Hughes NR, O'Brien PE (2004) Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (Baltimore, Md) 39 (6):1647-1654. https://doi.org/10.1002/hep.20251
Czaja AJ, Carpenter HA (2004) Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40 (4):646-652. https://doi.org/10.1016/j.jhep.2004.01.009
Parés A, Caballería J, Bruguera M, Torres M, Rodés J (1986) Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 2 (1):33–42. https://doi.org/10.1016/s0168-8278(86)80006-x
Hafeez S, Ahmed MH (2013) Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes 2013:839275. https://doi.org/10.1155/2013/839275
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (Baltimore, Md) 1 (5):431-435. https://doi.org/10.1002/hep.1840010511
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22 (6):696-699. https://doi.org/10.1016/0168-8278(95)80226-6
Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (3):372-374. https://doi.org/10.1016/0168-8278(91)90084-o
Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (12):1409–1417. https://doi.org/10.1097/00000478-199512000-00007
Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (Baltimore, Md) 24 (2):289–293. https://doi.org/10.1002/hep.510240201
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Network NSCR (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 41 (6):1313-1321. https://doi.org/10.1002/hep.20701
Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27 (12):1552-1558. https://doi.org/10.1038/modpathol.2014.79
Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md) 38 (6):1449-1457. https://doi.org/10.1016/j.hep.2003.09.022
Poynard T, Ratziu V, Bedossa P (2000) Appropriateness of liver biopsy. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 14 (6):543–548
Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, Cales P (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology (Baltimore, Md) 41 (2):257-264. https://doi.org/10.1002/hep.20535
Goodman ZD, Becker RL, Pockros PJ, Afdhal NH (2007) Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology (Baltimore, Md) 45 (4):886-894. https://doi.org/10.1002/hep.21595
Sun W, Chang S, Tai DC, Tan N, Xiao G, Tang H, Yu H (2008) Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt 13 (6):064010. https://doi.org/10.1117/1.3041159
Tai DC, Tan N, Xu S, Kang CH, Chia SM, Cheng CL, Wee A, Wei CL, Raja AM, Xiao G, Chang S, Rajapakse JC, So PT, Tang HH, Chen CS, Yu H (2009) Fibro-C-Index: comprehensive, morphology-based quantification of liver fibrosis using second harmonic generation and two-photon microscopy. J Biomed Opt 14 (4):044013. https://doi.org/10.1117/1.3183811
Gawrieh S, Sethunath D, Cummings OW, Kleiner DE, Vuppalanchi R, Chalasani N, Tuceryan M (2020) Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. Ann Diagn Pathol 47:151518. https://doi.org/10.1016/j.anndiagpath.2020.151518
Yu Y, Wang J, Ng CW, Ma Y, Mo S, Fong ELS, Xing J, Song Z, Xie Y, Si K, Wee A, Welsch RE, So PTC, Yu H (2018) Deep learning enables automated scoring of liver fibrosis stages. Sci Rep 8 (1):16016. https://doi.org/10.1038/s41598-018-34300-2
Bedossa P (2010) Harmony in liver fibrosis.. J Hepatol 52 (3):313-314. https://doi.org/10.1016/j.jhep.2009.11.020
Friedman SL (2008) Hepatic fibrosis -- overview. Toxicology 254 (3):120-129. https://doi.org/10.1016/j.tox.2008.06.013
Garcia-Tsao G, Friedman S, Iredale J, Pinzani M (2010) Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 51 (4):1445-1449. https://doi.org/10.1002/hep.23478
Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G (2006) Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 44 (1):111-117. https://doi.org/10.1016/j.jhep.2005.07.036
Kumar M, Sakhuja P, Kumar A, Manglik N, Choudhury A, Hissar S, Rastogi A, Sarin SK (2008) Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 27 (9):771-779. https://doi.org/10.1111/j.1365-2036.2008.03653.x
Kim MY, Cho MY, Baik SK, Park HJ, Jeon HK, Im CK, Won CS, Kim JW, Kim HS, Kwon SO, Eom MS, Cha SH, Kim YJ, Chang SJ, Lee SS (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55 (5):1004-1009. https://doi.org/10.1016/j.jhep.2011.02.012
Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G (2012) Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology (Baltimore, Md) 55 (4):1146-1153. https://doi.org/10.1002/hep.24805
Khalifa A, Rockey DC (2020) The utility of liver biopsy in 2020. Curr Opin Gastroenterol 36 (3):184-191. https://doi.org/10.1097/MOG.0000000000000621
Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344 (7):495-500. https://doi.org/10.1056/nejm200102153440706
Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, Group LS (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (7):1898-1906. https://doi.org/10.1053/j.gastro.2005.03.084
Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet (London, England) 1 (8480):523-525
Abdi W, Millan JC, Mezey E (1979) Sampling variability on percutaneous liver biopsy. Arch Intern Med 139 (6):667-669
Berzigotti A, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, Petta S, Thiele M, Tsochatzis E, Liver EAftSot, order) Lopma (2021) Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. J Hepatol. https://doi.org/10.1016/j.jhep.2021.05.025
Baranova A, Lal P, Birerdinc A, Younossi ZM (2011) Non-invasive markers for hepatic fibrosis. BMC Gastroenterol 11:91. https://doi.org/10.1186/1471-230X-11-91
Pinzani M, Rombouts K, Colagrande S (2005) Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 42 Suppl (1):S22–36. https://doi.org/10.1016/j.jhep.2004.12.008
Parikh P, Ryan JD, Tsochatzis EA (2017) Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med 5 (3):40. https://doi.org/10.21037/atm.2017.01.28
Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology (Baltimore, Md) 53 (3):726-736. https://doi.org/10.1002/hep.24105
Salkic NN, Jovanovic P, Hauser G, Brcic M (2014) FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Am J Gastroenterol 109 (6):796-809. https://doi.org/10.1038/ajg.2014.21
Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V (2007) Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 7:40. https://doi.org/10.1186/1471-230X-7-40
Houot M, Ngo Y, Munteanu M, Marque S, Poynard T (2016) Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Aliment Pharmacol Ther 43 (1):16-29. https://doi.org/10.1111/apt.13446
Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S (2014) The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis. PLoS One 9 (4):e92772. https://doi.org/10.1371/journal.pone.0092772
Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology (Baltimore, Md) 66 (5):1486-1501. https://doi.org/10.1002/hep.29302
Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB (2019) Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 7 (15):2022-2037. https://doi.org/10.12998/wjcc.v7.i15.2022
Dong B, Lyu G, Chen Y, Lin G, Wang H, Qin R, Gu J (2021) Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Rev Gastroenterol Hepatol 15 (9):1077-1089. https://doi.org/10.1080/17474124.2021.1880894
Lu Q, Lu C, Li J, Ling W, Qi X, He D, Liu J, Wen T, Wu H, Zhu H, Luo Y (2016) Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. Radiology 280 (1):290-299. https://doi.org/10.1148/radiol.2016151229
Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, Bernstien D, Maruyama H, Saraswat V, Chawla Y, Hamid S, Abbas Z, Bedossa P, Sakhuja P, Elmahatab M, Lim SG, Lesmana L, Sollano J, Jia JD, Abbas B, Omar A, Sharma B, Payawal D, Abdallah A, Serwah A, Hamed A, Elsayed A, AbdelMaqsod A, Hassanein T, Ihab A, GHaziuan H, Zein N, Kumar M (2017) Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int 11 (1):1-30. https://doi.org/10.1007/s12072-016-9760-3
Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT (2017) American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 152 (6):1544-1577. https://doi.org/10.1053/j.gastro.2017.03.016
Lim JK, Flamm SL, Singh S, Falck-Ytter YT, Association CGCotAG (2017) American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology 152 (6):1536-1543. https://doi.org/10.1053/j.gastro.2017.03.017
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md) 67 (1):328-357. https://doi.org/10.1002/hep.29367
Huber A, Ebner L, Heverhagen JT, Christe A (2015) State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. European Journal of Radiology Open 2:90-100. https://doi.org/10.1016/j.ejro.2015.05.002
Brown JJ, Naylor MJ, Yagan N (1997) Imaging of hepatic cirrhosis. Radiology 202 (1):1-16. https://doi.org/10.1148/radiology.202.1.8988182
Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, Vilgrain V (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61 (1):57-69. https://doi.org/10.1016/j.ejrad.2006.11.003
Dodd GD, Baron RL, Oliver JH, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173 (4):1031-1036. https://doi.org/10.2214/ajr.173.4.10511173
Zhang YN, Fowler KJ, Boehringer AS, Montes V, Schlein AN, Covarrubias Y, Wolfson T, Hong CW, Valasek MA, Andre MP, Loomba R, Sirlin CB (2021) Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. Eur Radiol. https://doi.org/10.1007/s00330-021-08369-9
Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R (2019) Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol 17 (4):630-637.e638. https://doi.org/10.1016/j.cgh.2018.05.059
Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, Levick CK, Young LAJ, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M, Investigators L (2021) Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol 75 (4):770-785. https://doi.org/10.1016/j.jhep.2021.04.044
Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, Behling C, Valasek MA, Loomba R (2021) Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Therap Adv Gastroenterol 14:17562848211050436. https://doi.org/10.1177/17562848211050436
Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13 (3):440-451.e446. https://doi.org/10.1016/j.cgh.2014.09.046
Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26 (5):1431-1440. https://doi.org/10.1007/s00330-015-3949-z
Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology (Baltimore, Md) 56 (1):239-247. https://doi.org/10.1002/hep.25610
Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver International 33 (8):1138-1147. https://doi.org/10.1111/liv.12240
Hu X, Qiu L, Liu D, Qian L (2017) Acoustic Radiation Force Impulse (ARFI) Elastography for non‑invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis. Med Ultrason 19 (1):23-31. https://doi.org/10.11152/mu-942
Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, Kessoku T, Ogawa Y, Takahashi H, Saigusa Y, Yoneda M, Kirikoshi H, Utsunomiya D, Aishima S, Saito S, Nakajima A (2020) Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.12.016
Takayama Y, Nishie A, Asayama Y, Ushijima Y, Okamoto D, Fujita N, Morita K, Shirabe K, Kotoh K, Kubo Y, Okuaki T, Honda H (2015) T1 ρ Relaxation of the liver: A potential biomarker of liver function. J Magn Reson Imaging 42 (1):188-195. https://doi.org/10.1002/jmri.24739
Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60 (1):69-77. https://doi.org/10.1016/j.jhep.2013.09.002
Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP (2020) T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol (NY) 45 (3):692-700. https://doi.org/10.1007/s00261-019-02382-9
Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X (2016) Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology 280 (3):771-781. https://doi.org/10.1148/radiol.2016151542
Lubner MG, Jones D, Said A, Kloke J, Lee S, Pickhardt PJ (2018) Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol (NY). https://doi.org/10.1007/s00261-018-1572-6
Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. AJR Am J Roentgenol 207 (6):1194-1199. https://doi.org/10.2214/AJR.16.16514
Kim SW, Kim YR, Choi KH, Cho EY, Song JS, Kim JE, Kim TH, Lee YH, Yoon KH (2020) Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI. AJR Am J Roentgenol 215 (3):624-630. https://doi.org/10.2214/AJR.19.22041
Catania R, Furlan A, Smith AD, Behari J, Tublin ME, Borhani AA (2021) Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. Eur Radiol 31 (1):256-263. https://doi.org/10.1007/s00330-020-07114-y
Dioguardi Burgio M, Sartoris R, Beaufrere A, Grégory J, Guiu B, Guillot C, Rautou PE, Castera L, Bouattour M, Paradis V, Vilgrain V, Ronot M (2021) Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD. Eur Radiol. https://doi.org/10.1007/s00330-021-08261-6
Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G (2020) Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology 296 (2):263-274. https://doi.org/10.1148/radiol.2020192437
Schawkat K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, Jüngst C, Weber A, Gubler C, Mertens J, Reiner CS (2020) Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology. Eur Radiol 30 (8):4675-4685. https://doi.org/10.1007/s00330-020-06831-8
Lubner MG, Jones D, Kloke J, Said A, Pickhardt PJ (2019) CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus. Br J Radiol 92 (1093):20180153. https://doi.org/10.1259/bjr.20180153
Choi KJ, Jang JK, Lee SS, Sung YS, Shim WH, Kim HS, Yun J, Choi JY, Lee Y, Kang BK, Kim JH, Kim SY, Yu ES (2018) Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver. Radiology 289 (3):688-697. https://doi.org/10.1148/radiol.2018180763
Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S (2018) Deep learning for staging liver fibrosis on CT: a pilot study. Eur Radiol 28 (11):4578-4585. https://doi.org/10.1007/s00330-018-5499-7
Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S (2018) Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images. Radiology 287 (1):146-155. https://doi.org/10.1148/radiol.2017171928
Hectors SJ, Kennedy P, Huang KH, Stocker D, Carbonell G, Greenspan H, Friedman S, Taouli B (2021) Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI. Eur Radiol 31 (6):3805-3814. https://doi.org/10.1007/s00330-020-07475-4
Phelps A (2019) Liver Ultrasound Texture Analysis: The Computer Finds More to Quantify Than Meets the Eye. Acad Radiol 26 (8):1008-1009. https://doi.org/10.1016/j.acra.2019.03.013
Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO (2005) Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 25 (6):1142-1149. https://doi.org/10.1111/j.1478-3231.2005.01155.x
Masugi Y, Abe T, Tsujikawa H, Effendi K, Hashiguchi A, Abe M, Imai Y, Hino K, Hige S, Kawanaka M, Yamada G, Kage M, Korenaga M, Hiasa Y, Mizokami M, Sakamoto M (2018) Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun 2 (1):58-68. https://doi.org/10.1002/hep4.1121
Poynard T, Lenaour G, Vaillant JC, Capron F, Munteanu M, Eyraud D, Ngo Y, M'Kada H, Ratziu V, Hannoun L, Charlotte F (2012) Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 10 (6):657-663.e657. https://doi.org/10.1016/j.cgh.2012.01.023
Mehta SH, Lau B, Afdhal NH, Thomas DL (2009) Exceeding the limits of liver histology markers. J Hepatol 50 (1):36-41. https://doi.org/10.1016/j.jhep.2008.07.039
Acknowledgements
Dr. Venkatesh acknowledges support from National Institute of Health Grant (EB001981) and U.S. Department of Defense Grant (W81XWH-19-1-0583-01).
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Financial interests: The author declares no financial interests. Non-financial interests: The author declares no non-financial interests.
Research involving human participants and/or animals
This review article did not involve any research involving human participants and/or animals. No ethics approval was needed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Venkatesh, S.K., Torbenson, M.S. Liver fibrosis quantification. Abdom Radiol 47, 1032–1052 (2022). https://doi.org/10.1007/s00261-021-03396-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-021-03396-y